Diabetic ketoacidosis shortly after COVID‐19 vaccination in a non–small‐cell lung cancer patient receiving combination of PD‐1 and CTLA‐4 inhibitors: A case report

We describe a case of diabetic ketoacidosis (DKA) shortly after the SARS‐CoV‐2 (COVID‐19) vaccination in a 65‐year‐old woman with non–small‐cell lung cancer under a combination treatment of programmed cell death protein 1 (PD‐1) and cytotoxic T‐lymphocyte‐associated protein 4 (CTLA‐4) inhibitors. Sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Makiguchi, Tomonori, Fukushima, Takashi, Tanaka, Hisashi, Taima, Kageaki, Takayasu, Shinobu, Tasaka, Sadatomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013655/
https://www.ncbi.nlm.nih.gov/pubmed/35166047
http://dx.doi.org/10.1111/1759-7714.14352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013655/
https://www.ncbi.nlm.nih.gov/pubmed/35166047
http://dx.doi.org/10.1111/1759-7714.14352

Ejemplares similares